End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.97 USD | 0.00% | -1.73% | -9.15% |
Feb. 25 | Birzeit Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 09 | What does the Gotham City report say about Grifols? | RE |
Financials (USD)
Sales 2022 | 47.03M | Sales 2023 | 43.13M | Capitalization | 169M |
---|---|---|---|---|---|
Net income 2022 | 7M | Net income 2023 | 6M | EV / Sales 2022 | 3.31 x |
Net cash position 2022 | 15.41M | Net cash position 2023 | 17.19M | EV / Sales 2023 | 3.53 x |
P/E ratio 2022 |
21.5
x | P/E ratio 2023 |
27.3
x | Employees | - |
Yield 2022 |
2.27% | Yield 2023 |
-
| Free-Float | 73.92% |
1 week | -1.73% | ||
Current month | -5.02% | ||
1 month | -2.93% | ||
3 months | -6.37% | ||
6 months | -3.17% | ||
Current year | -9.15% |
Managers | Title | Age | Since |
---|---|---|---|
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 84-03-31 |
Director of Finance/CFO | - | 84-11-14 | |
Chief Tech/Sci/R&D Officer | - | 97-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 20-12-31 | |
Chief Administrative Officer | 54 | 91-12-31 | |
Talal Nasereddin
CEO | Chief Executive Officer | 74 | 84-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-27 | 3.97 | 0.00% | 2 000 |
24-05-26 | 3.97 | -1.49% | 1,150 |
24-05-23 | 4.03 | +0.75% | 12,500 |
24-05-22 | 4 | -0.99% | 2,667 |
End-of-day quote Palestine Exchange, May 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-9.15% | 154M | |
+16.31% | 42.32B | |
+16.32% | 21.29B | |
+19.33% | 15.29B | |
+18.71% | 14.36B | |
+52.78% | 12.81B | |
-0.05% | 6.79B | |
-12.24% | 6.58B | |
-8.87% | 5.73B | |
+11.64% | 5.51B |
- Stock Market
- Equities
- BPC Stock